Sciences de la vie - soins de santé

Bienvenue sur la page d'accueil sciences de la vie - soins de santé de Law-Now.

Sur cette page, vous pouvez accéder à des articles et des publications relatifs au sciences de la vie - soins de santé, rédigés par les experts de CMS.

Pour rester informés des dernières évolutions, veuillez ajouter cette page à vos favoris sur votre mobile ou vous inscrire pour recevoir les eAlerts.

eAlerts Récentes

  •  
    10/02/2025
    United Kingdom

    Increased regulation of high risk and weight loss medication – will new GPhC guidance strengthen safeguards and prevent unsafe online supply?

    As access to medication becomes more convenient with the increased use of online pharmacies, concerns have emerged about the safety and appropriateness of prescribing certain drugs at a distance, particularly high-risk drugs such as weight loss medication. As demand for medication supply online increases, with popularity surging as a result of social media for high-risk drugs such as weight loss medication, questions around proper patient screening and potential misuse have been raised. The General Pharmaceutical Council (GPhC) have addressed this issue and supplying at a distance generally, in...
    Lire la suite
  •  
    31/01/2025
    United Kingdom

    CMS Life Sciences Vital Signs Winter 2024/2025

    In our winter edition of Vital Signs we review how the new Labour Government in the UK aims to bring about significant changes to the life sciences & healthcare sector. We consider some key aspects of the party’s pre-election life sciences strategy and some sector-targeted actions taken by Labour since winning power. The Labour Government has also delivered on its promise to introduce an Employment Rights Bill within its first 100 days of office which it has described as the “biggest upgrade to rights at work for a generation”. That, along with a new duty to prevent sexual...
    Lire la suite
  •  
    24/01/2025
    Ukraine

    Ukraine introduces updated labelling regulations for medicines

    On 18 January 2025, new labelling requirements for medicinal products in Ukraine went into force. These amendments restrict promotional information on labelling, prohibit references to entities other than the manufacturer or marketing authorisation holder (MAH) on packaging, and grant new powers to the Ministry of Health and the Quality Inspectorate to suspend marketing authorisations and circulation of non-compliant medicines. Pharmaceutical companies must address these regulatory changes and ensure compliance.In a previous Law-Now article, we provided analysis of the official interpretations...
    Lire la suite
  •  
    16/01/2025
    International

    CMS Expert Guide on Beauty

    With a highly circumspect online and IRL consumer, the beauty industry is facing increasing scrutiny on everything from ingredients to their supply chain. For those offering treatment services in particular, which has until now been the wild west of wellness, there’s a shift in consumer demand for transparency and accountability – namely a desire for better regulation and insurance. This follows well documented horror stories in national press worldwide of those travelling to secure these services at bargain prices with catastrophic results.This Expert Guide on Beauty considers...
    Lire la suite
  •  
    16/01/2025
    England and Wales

    CQC evidence to the Health and Social Care Committee shows the scale of operational failings

    The CQC Chair and Chief Executive, Ian Dilks and Sir Julian Hartley, appeared before the Health and Social Care Committee yesterday, 15 January 2025.  Their evidence revealed the extent of the operational failings following the disastrous transformation plan and the scale of the improvement needed to restore confidence in the regulator, which Sir Julian Hartley said would be addressed initially through four priorities:Complete more assessmentsDeal with backlogs in notificationsGet the 500 “stuck” assessments out of the regulatory platformReduce the time to register servicesAverage...
    Lire la suite
  •  
    15/01/2025
    Chine

    2025 – Topics that may Concern You

    Companies doing business in China constantly have to deal with changes in regulations and new laws. This will also continue in 2025.Topics such as the new PRC Company Law, new PRC Tariff Law, PRC Regulations on Export Control of Dual-Use Items, network data security management, data transfer, opening up capital markets to foreign investment, and raise of statutory retirement age of employees etc. will continue to be a concern for many companies in China in 2025.Complying with regulatory requirements is one of the key challenges for foreign companies and investors in China, not only in terms of...
    Lire la suite